https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-22 / Blood 2017 10;130(15):1713-1721
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-22 / Blood 2017 10;130(15):1713-17212017-08-22 00:00:002019-02-15 08:32:49Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e52017-08-14 00:00:002017-08-14 00:00:00Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-08-01 / Melanoma Res 2017 08;27(4):351-357
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-08-01 / Melanoma Res 2017 08;27(4):351-3572017-08-01 00:00:002017-08-01 00:00:00Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-27 / J. Virol. 2017 08;91(16)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-27 / J. Virol. 2017 08;91(16)2017-07-27 00:00:002017-07-27 00:00:00Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-561
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-5612017-07-26 00:00:002019-02-15 08:37:24Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-25 / J Hematol Oncol 2017 07;10(1):142
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-25 / J Hematol Oncol 2017 07;10(1):1422017-07-25 00:00:002019-02-15 08:32:50Recent developments in immunotherapy of acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-25 / Front Pharmacol 2017;8:495
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-25 / Front Pharmacol 2017;8:4952017-07-25 00:00:002019-02-15 08:32:55Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-25 / J Glob Oncol 2018 Sep;4:1-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-25 / J Glob Oncol 2018 Sep;4:1-42017-07-25 00:00:002017-07-25 00:00:00Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-19 / Int J Cancer 2017 11;141(9):1891-19002017-07-19 00:00:002021-11-15 20:03:02Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-1264
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-12642017-07-15 00:00:002019-02-15 09:23:07Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
